113 related articles for article (PubMed ID: 16939752)
1. Topical fluticasone propionate lotion does not cause HPA axis suppression.
Hebert AA; Friedlander SF; Allen DB
J Pediatr; 2006 Sep; 149(3):378-82. PubMed ID: 16939752
[TBL] [Abstract][Full Text] [Related]
2. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis.
Schlessinger J; Miller B; Gilbert RD; Plott RT;
Arch Dermatol; 2006 Dec; 142(12):1568-72. PubMed ID: 17178982
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
Abramovits W; Oquendo M
Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
[TBL] [Abstract][Full Text] [Related]
4. Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis.
Eichenfield LF; Basu S; Calvarese B; Trancik RJ
Pediatr Dermatol; 2007; 24(3):289-95. PubMed ID: 17542883
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma.
Iles R; Williams RM; Deeb A; Ross-Russell R; Acerini CL
Pediatr Pulmonol; 2008 Apr; 43(4):354-9. PubMed ID: 18286548
[TBL] [Abstract][Full Text] [Related]
6. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E
Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
[TBL] [Abstract][Full Text] [Related]
8. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
[TBL] [Abstract][Full Text] [Related]
9. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
[TBL] [Abstract][Full Text] [Related]
10. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
Kimball AB; Gold MH; Zib B; Davis MW;
J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
[TBL] [Abstract][Full Text] [Related]
11. HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis.
Tripathy I; Levy A; Ratner P; Clements D; Wu W; Philpot E
Pediatr Allergy Immunol; 2009 May; 20(3):287-94. PubMed ID: 19175889
[TBL] [Abstract][Full Text] [Related]
12. Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from 3 months of age.
Eichenfield LF; Miller BH;
J Am Acad Dermatol; 2006 Apr; 54(4):715-7. PubMed ID: 16546598
[TBL] [Abstract][Full Text] [Related]
13. Impaired recovery of hypothalamic-pituitary-adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler.
Kennedy MJ; Carpenter JM; Lozano RA; Castile RG
Ann Allergy Asthma Immunol; 2002 May; 88(5):523-6. PubMed ID: 12027076
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls?
Glazenburg EJ; Wolkerstorfer A; Gerretsen AL; Mulder PG; Oranje AP
Pediatr Allergy Immunol; 2009 Feb; 20(1):59-66. PubMed ID: 18298423
[TBL] [Abstract][Full Text] [Related]
15. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
16. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.
Lucky AW; Grote GD; Williams JL; Tuley MR; Czernielewski JM; Dolak TM; Herndon JH; Baker MD
Cutis; 1997 Mar; 59(3):151-3. PubMed ID: 9071556
[TBL] [Abstract][Full Text] [Related]
17. Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis.
Oranje AP; Verbeek R; Verzaal P; Haspels I; Prens E; Nagelkerken L
Br J Dermatol; 2009 Jan; 160(1):54-61. PubMed ID: 18795918
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution.
Wolkerstorfer A; Visser RL; De Waard van der Spek FB; Mulder PG; Oranje AP
Br J Dermatol; 2000 Nov; 143(5):999-1004. PubMed ID: 11069509
[TBL] [Abstract][Full Text] [Related]
19. Intranasal corticosteroids and adrenal suppression.
Bruni FM; De Luca G; Venturoli V; Boner AL
Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
[TBL] [Abstract][Full Text] [Related]
20. Fluticasone propionate in the treatment of inflammatory dermatoses.
Chu AC; Munn S
Br J Clin Pract; 1995; 49(3):131-3. PubMed ID: 7779663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
